An Observational, Multicentre, Open label, Post-Marketing Surveillance Program to assess the long-term safety and efficacy of Somatuline® Autogel® in the treatment of acromegaly when administered by patients or their partners (“Home Injection Group”) or administered by Healthcare Professionals